Overview
1. Therapy of neuromuscular disease - immunologic and neuromuscular facilitating agents for myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS).
2. Clinical trials in nerve, muscle and neuromuscular diseases
Current Appointments & Affiliations
Professor Emeritus of Neurology
·
2025 - Present
Neurology, Neuromuscular Disease,
Neurology
Recent Publications
Sensitivity of Repetitive Nerve Stimulation Performed in Early and Later Stages of Myasthenia Gravis.
Journal Article Muscle Nerve · October 2025 INTRODUCTION/AIMS: Repetitive nerve stimulation (RNS) is a valuable tool in the diagnostic evaluation of myasthenia gravis (MG). However, there are conflicting reports of its sensitivity when performed ≤ 30 days from symptom onset. We aim to compare the se ... Full text Link to item CiteAn observational study of the lung microbiome and lung function in young children with cystic fibrosis across two countries with differing antibiotic practices.
Journal Article Microb Pathog · August 2025 BACKGROUND: Cystic fibrosis (CF) lung disease begins early, and prophylactic antibiotics have been used to prevent Staphylococcus aureus infection. This study examined the lung microbiome in two countries with differing antibiotic practices and its relatio ... Full text Link to item CiteAuthors' Reply.
Journal Article J Clin Neuromuscul Dis · March 1, 2025 Full text Link to item CiteRecent Grants
Defining the clinical phenotype and immunopathology of seronegative MG
ResearchKey Faculty · Awarded by Myasthenia Gravis Foundation · 2021 - 2023Prospective Multicenter Observational Cohort Study of Comparative Effectiveness of Disease-Modifying Treatments for Myasthenia Gravis (MG)
Clinical TrialPrincipal Investigator · Awarded by Patient-Centered Outcomes Research Institute · 2017 - 2022Real World Outcomes of Surgical and Medical Management in Myasthenia Gravis
ResearchMentor · Awarded by American Academy of Neurology · 2019 - 2022View All Grants
Education, Training & Certifications
Harvard University ·
1964
M.D.